Vtv Theraptcs Cl A (VTVT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2024 | 12-2023 | 12-2022 | 12-2021 | 12-2020 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -22,705 | -25,966 | -25,073 | -17,731 | -12,802 |
| Depreciation Amortization | 89 | 90 | 92 | 89 | 474 |
| Accounts receivable | 40 | 71 | -116 | 101 | -153 |
| Other Working Capital | -5,438 | 4,394 | 5,385 | 35 | -2,706 |
| Other Operating Activity | 2,707 | 2,330 | 3,690 | -1,802 | -2,813 |
| Operating Cash Flow | $-25,307 | $-19,081 | $-16,022 | $-19,308 | $-18,000 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | N/A | N/A | -21 | N/A | N/A |
| Sale Of Investment | N/A | 4,404 | N/A | N/A | N/A |
| Investing Cash Flow | $N/A | $4,404 | $-21 | $N/A | $0 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | 566 | 776 | 887 | 500 |
| Common Stock Issued | 52,798 | 12,030 | 14,786 | 26,804 | 24,426 |
| Other Financing Activity | -191 | -599 | -808 | -715 | -5,456 |
| Financing Cash Flow | $52,607 | $11,997 | $14,754 | $26,976 | $19,470 |
| Beginning Cash Position | 9,446 | 12,126 | 13,415 | 5,747 | 4,277 |
| End Cash Position | 36,746 | 9,446 | 12,126 | 13,415 | 5,747 |
| Net Cash Flow | $27,300 | $-2,680 | $-1,289 | $7,668 | $1,470 |
| Free Cash Flow | |||||
| Operating Cash Flow | -25,307 | -19,081 | -16,022 | -19,308 | -18,000 |
| Capital Expenditure | 0 | 0 | -21 | N/A | 0 |
| Free Cash Flow | -25,307 | -19,081 | -16,043 | -19,308 | -18,000 |